Literature DB >> 29452449

Efficacy of Natalizumab in Intermediate Uveitis Related to Multiple Sclerosis: A Case Report.

Ségolène Roemer1, Alexandre Bissig1, Alda Rocca2, Renaud Du Pasquier3, Yan Guex-Crosier1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29452449     DOI： 10.1055/s-0043-124756

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN： 0023-2165            Impact factor:   0.700


× No keyword cloud information.
  3 in total

Review 1.  A Comprehensive Update on Retinal Vasculitis: Etiologies, Manifestations and Treatments.

Authors:  Aniruddha Agarwal; Anne Rübsam; Lynn Zur Bonsen; Francesco Pichi; Piergiorgio Neri; Uwe Pleyer
Journal:  J Clin Med       Date:  2022-04-30       Impact factor: 4.964

Review 2.  Adhesion Molecule Targeted Therapy for Non-Infectious Uveitis.

Authors:  Yi-Hsing Chen; Sue Lightman; Malihe Eskandarpour; Virginia L Calder
Journal:  Int J Mol Sci       Date:  2022-01-03       Impact factor: 5.923

Review 3.  Intermediate uveitis associated with MS: Diagnosis, clinical features, pathogenic mechanisms, and recommendations for management.

Authors:  Alan Abraham; Lindsay Nicholson; Andrew Dick; Claire Rice; Denize Atan
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2020-10-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.